Background The clinical and epidemiological significance of Leishmania DNA in extralesional sites is obscured by uncertainty of whether the DNA derives from viable parasites. To examine dissemination of Leishmania during active disease and the potential participation of human infection in transmission, Leishmania 7SLRNA was exploited to establish viability and estimate parasite burden in extralesional sites of dermal leishmaniasis patients. Methods The feasibility of discriminating parasite viability by PCR of Leishmania 7SLRNA was evaluated in relation with luciferase activity of luc transfected intracellular amastigotes in dose-response assays of Glucantime cytotoxicity. Monocytes, tonsil swabs, aspirates of normal skin and lesions of 28 cutaneous and 2 mucocutaneous leishmaniasis patients were screened by kDNA amplification/Southern blot. Positive samples were analyzed by quantitative PCR of Leishmania 7SLRNA genes and transcripts. Results 7SLRNA amplification coincided with luciferase activity, confirming discrimination of parasite viability. Of 22 patients presenting kDNA in extralesional samples, Leishmania 7SLRNA genes or transcripts were detected in one or more kDNA positive samples in 100% and 73% of patients, respectively. Gene and transcript copy number amplified from extralesional tissues were comparable to lesions. 7SLRNA transcripts were detected in 13/19 (68%) monocyte samples, 5/12 (42%) tonsil swabs, 4/11 (36%) normal skin aspirates, and 22/25 (88%) lesions; genes were quantifiable in 15/19 (79%) monocyte samples, 12/13 (92%) tonsil swabs, 8/11 (73%) normal skin aspirates. Conclusion Viable parasites are present in extralesional sites, including blood monocytes, tonsils and normal skin of dermal leishmaniasis patients. Leishmania 7SLRNA is an informative target for clinical and epidemiologic investigations of human leishmaniasis.
References
[1]
Schubach A, Haddad F, Oliveira-Neto M, Degrave W, Pirmez C, et al. (1998) Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 178: 911–914. doi: 10.1086/515355
[2]
Rojas R, Valderrama L, Valderrama M, Varona M, Ouellette M, et al. (2006) Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis 193: 1375–1383. doi: 10.1086/503371
[3]
Schulz A, Mellenthin K, Schonian G, Fleischer B, Drosten C (2003) Detection, differentiation, and quantitation of pathogenic Leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41: 1529–1535. doi: 10.1128/JCM.41.4.1529-1535.2003
[4]
Castilho T, Camargo L, McMahon-Pratt D, Shaw J, Floeter-Winter L (2008) A real-time polymerase chain reaction assay for the identification and quantification of American Leishmania species on the basis of glucose-6-phosphate dehydrogenase. Am J Trop Med Hyg 78: 122–132.
[5]
Figueroa R, Lozano L, Romero I, Cardona M, Prager M, et al. (2009) Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species. J Infect Dis 200: 638–646. doi: 10.1086/600109
[6]
Mendon？a M, de Brito M, Rodrigues E, Bandeira V, Jardim M, et al. (2004) Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 189: 1018–1023. doi: 10.1086/382135
[7]
Vergel C, Palacios R, Cadena H, Posso C, Valderrama L, et al. (2006) Evidence for Leishmania (viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis 194: 503–511. doi: 10.1086/505583
[8]
Osman O, Oskam L, Zijlstra E, el-Hassan A, el-Naeim D, et al. (1998) Use of the polymerase chain reaction to assess the success of visceral Leishmaniasis treatment. Trans R Soc Trop Med Hyg 92: 397–400. doi: 10.1016/S0035-9203(98)91063-X
[9]
Keer J, Birch L (2003) Molecular methods for the assessment of bacterial viability. J Microbiol Meth 53 175-183: doi: 10.1016/s0167-7012(03)00025-3
[10]
Van der Meide W, Schoone G, Faber W, Zeegelaar J, de Vries H, et al. (2005) Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples. J Clin Microbiol 43: 5560–5566. doi: 10.1128/JCM.43.11.5560-5566.2005
[11]
Zelazny A, Fedorko D, Li L, Neva F, Fischer S (2005) Evaluation of 7SL RNA gene sequences for the identification of Leishmania spp. Am J Trop Med Hyg 72: 415–420.
[12]
Michaeli S, Podell D, Agabian N, Ullu E (1992) The 7SL RNA homologue of Trypanosoma brucei is closely related to mammalian 7SL RNA. Mol Biochem Parasitol 51: 55–64. doi: 10.1016/0166-6851(92)90200-4
[13]
Roy G, Dumas C, Sereno D, Wu Y, Singh A, et al. (2000) Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110: 195–206. doi: 10.1016/S0166-6851(00)00270-X
[14]
Hendricks L, Wright N (1979) Diagnosis of cutaneous leishmaniasis by in vitro cultivation of saline aspirates in Schneider's Drosophila Medium. Am J Trop Med Hyg 28: 962–964.
[15]
Romero I, Saravia N, Walker J (2005) Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro. J Parasitol 91: 1474–1479. doi: 10.1645/GE-3489.1
[16]
Wortmann G, Aronson N, Miller R, Blazes D, Oster C (2000) Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 31: 199–201. doi: 10.1086/313924
[17]
Vergel C, Walker J, Saravia N (2005) Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction. Am J Trop Med Hyg 72: 423–429.
[18]
Peacock C, Seeger K, Harris D, Murphy L, Ruiz J, et al. (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39: 839–847. doi: 10.1038/ng2053
[19]
Coutard F, Lozach S, Pommepuy M, Hervio D (2007) Heath Real-Time Reverse Transcription-PCR for Transcriptional Expression Analysis of Virulence and Housekeeping Genes in Viable but Nonculturable Vibrio parahaemolyticus after Recovery of Culturability. Appl Environ Microbiol 73: 5183–5189. doi: 10.1128/AEM.02776-06
[20]
Kuglstatter A, Oubridge C, Nagai K (2002) Induced structural changes of 7SL RNA during the assembly of human signal recognition particle. Nat Struct Biol 9: 740–744. doi: 10.1038/nsb843
[21]
McCarty S, Atlas R (1993) Effect of amplicon size on PCR detection of bacteria exposed to chlorine. PCR Methods Appl 3: 181–185. doi: 10.1101/gr.3.3.181
[22]
Martinez J, Arias L, Escobar M, Saravia N (1992) Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination. Trans R Soc Trop Med Hyg 86: 392–394. doi: 10.1016/0035-9203(92)90233-3
[23]
Schubach A, Marzochi MC, Cuzzi-Maya T, Oliveira AV, Araujo ML, et al. (1998) Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 58: 824–827.
[24]
Van der Meide W, Guerra J, Schoone G, Farenhorst M, Coelho L, et al. (2008) Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites. J Clin Microbiol 46: 73–78. doi: 10.1128/JCM.01416-07
